GT BIOPHARMA INC COM

GT BIOPHARMA INC COM is a security (CUSIP 36254L308) tracked across SEC portfolio filings. 50 institutional managers reported $510K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $184K via N-PORT as of 2026-05-29.

Summary

Top institutional holders (Form 13F)

Showing 15 of 50 managers by value.

ManagerLocationValueShares
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$120K294,459
Everhart Financial Group, Inc.Dublin, OH$49K100,000
Opal Wealth Advisors, LLCJERICHO, NY$40K81,811
SRS Capital Advisors, Inc.DENVER, CO$38K93,627
CITADEL ADVISORS LLCMIAMI, FL$27K66,165
SeaCrest Wealth Management, LLCPURCHASE, NY$25K50,100
KITCHING PARTNERS, LLCCONSHOHOCKEN, PA$24K50,000
UBS Group AGZurich, V8$19K45,970
TWO SIGMA SECURITIES, LLCNew York, NY$13K31,796
LPL Financial LLCFORT MILL, SC$12K30,382
SAGESPRING WEALTH PARTNERS, LLCFRANKLIN, TN$10K20,000
Private Wealth Management Group, LLCPRINCETON, NJ$10K20,000
Invst, LLCINDIANAPOLIS, IN$10K23,400
OSAIC HOLDINGS, INC.PHOENIX, AZ$9K21,000
Keel Point, LLCHUNTSVILLE, AL$8K20,768

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$184K0.02%
Guggenheim Active Allocation FundGuggenheim Active Allocation Fund$10.00%

More